Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | HMGCR | P04035 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | ACLY | P53396 | 3/20 | 0.32 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CPT2 | P23786 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16418481 | 0.87 | TSHR (0.37) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL873725 | 0.85 | TSHR (0.45) | ALDH1A1TSHRHTTABCC4MAPT | |
| SCHEMBL17818667 | 0.82 | ALDH1A1 (0.43) | ALDH1A1TSHRHTTABCC4MAPT | |
| SCHEMBL25199379 | 0.80 | ALDH1A1 (0.36) | ALDH1A1TSHRHTT | |
| SCHEMBL2580506 | 0.77 | ALDH1A1 (0.37) | ALDH1A1TSHRHTTABCC4MAPT | |
| SCHEMBL16823397 | 0.76 | ALDH1A1 (0.39) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL29901361 | 0.76 | ALDH1A1 (0.39) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| Boric Acid SCHEMBL28756071 | 0.76 | ALDH1A1 (0.39) | ALDH1A1TSHRHTT | |
| SCHEMBL462608 | 0.76 | ALDH1A1 (0.39) | ALDH1A1TSHRHTT | |
| SCHEMBL10544728 | 0.76 | ALDH1A1 (0.39) | ALDH1A1TSHRHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-9279478-A | — | — | None | — | — | JP | disclosed |
| US-20240066132-A1 | NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | NOVARTIS AG (CH) | 2024-02-29 | — | — | US | disclosed |
| US-11752211-B2 | Fatty acids and their use in conjugation to biomolecules | NOVARTIS AG (CH) | 2023-09-12 | — | — | US | disclosed |
| US-20170107248-A1 | SITE SPECIFIC PROTEIN MODIFICATIONS | NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC. | 2017-04-20 | — | — | US | disclosed |
| US-9266925-B2 | Cyclic polypeptides for the treatment of heart failure | NOVARTIS AG (CH) | 2016-02-23 | — | — | US | disclosed |
| US-20160030585-A1 | NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | NOVARTIS AG (CH) | 2016-02-04 | — | — | US | disclosed |
| US-20150031604-A1 | CYCLIC POLYPEPTIDES FOR THE TREATMENT OF HEART FAILURE | NOVARTIS AG (CH) | 2015-01-29 | — | — | US | disclosed |
| JP-H09279478-A | TREATING AGENT FOR FIBER | NOF CORP | 1997-10-28 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160030585-A1 | NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | FABP1, FABP2, FABP3 | ALDH1A1 849/4885TSHR 828/4885CYP2D6 2119/4885 |
| US-20150031604-A1 | CYCLIC POLYPEPTIDES FOR THE TREATMENT OF HEART FAILURE | NPY1R, ACKR3, IAPP | ALDH1A1 2536/4885TSHR 1003/4885CYP2D6 2010/4885 |
| US-20240066132-A1 | NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | FABP1, FABP2, FABP3 | ALDH1A1 849/4885TSHR 828/4885CYP2D6 2119/4885 |
| US-11752211-B2 | Fatty acids and their use in conjugation to biomolecules | FABP1, FABP2, FABP3 | ALDH1A1 907/4885TSHR 620/4885CYP2D6 1688/4885 |
| US-20170107248-A1 | SITE SPECIFIC PROTEIN MODIFICATIONS | PTMS, DNPEP, ANPEP | ALDH1A1 4438/4885TSHR 2557/4885CYP2D6 4430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.